Más leídos en el último sumario

• 431

  Clinical association of the SCN5A c.2302A>G variant (p.Ile768Val) with Brugada syndrome

  Boris Kuzmicic Calderón, Bernardita Martínez Galdames, Mario Hassi Thumala, Jorge Van Grieken, Jovan Kuzmicic

  Rev Esp Cardiol. 2025;78:657-9

• 475

  Recurrent chronic thromboembolic pulmonary hypertension following balloon pulmonary angioplasty

  Claudio M. Rivadulla Varela, Ignacio Fernández Herrero, Nicolás Maneiro Melón, Fernando Sarnago Cebada, Pilar Escribano Subías, Maite Velázquez Martín

  Rev Esp Cardiol. 2025;78:655-7

• 560

  Synovial sarcoma causing right ventricular outflow tract obstruction

  Leizhi Ku, Youping Chen, Xiaojing Ma

  Rev Esp Cardiol. 2025;78:663-4

• 609

  Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes

  Sergio López-Tejero, Pablo Antúnez-Muiños, Miguel Hernández-Hidalgo, Ana Martín-García, Pedro L. Sánchez-Fernández, Ignacio Cruz-González

  Rev Esp Cardiol. 2025;78:659-62

• 714

  The Cardiovascular Health Strategy of the National Health System (ESCAV). A great opportunity and responsibility for all

  Luis Rodríguez Padial, Julián Pérez Villacastín

  Rev Esp Cardiol. 2025;78:637-8

• 747

  Safety and efficacy of antiplatelet therapy in patients with intermediate coronary artery stenosis and deferred revascularization

  David Hong, Seung Hun Lee, Jihye Heo, Doosup Shin, Juhee Cho, Eliseo Guallar, Hyun Sung Joh, Hyun Kuk Kim, Junho Ha, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Danbee Kang, Joo Myung Lee

  Rev Esp Cardiol. 2025;78:580-9

• 756

  Population-based analysis of the cost of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation

  Zojaina Hernández Rojas, M. Rosa Dalmau Llorca, Carina Aguilar Martín, Elisabet Castro Blanco, Manuel García-Goñi, Josep M. Alegret

  Rev Esp Cardiol. 2025;78:652-5

• 760

  Accessory pathway ablation in persistent left superior vena cava

  Finn Åkerström, Astrid Paul-Nordin

  Rev Esp Cardiol. 2025;78:665

• 832

  Association between autoimmune diseases and all-cause mortality in patients with cardiac arrhythmia

  Le Li, Lingmin Wu, Zhicheng Hu, Limin Liu, Likun Zhou, Zhuxin Zhang, Minghao Zhao, Yulong Xiong, Zhenhao Zhang, Lihui Zheng, Ligang Ding, Yan Yao

  Rev Esp Cardiol. 2025;78:609-17

• 918

  Antiplatelet therapy for primary prevention of nonsignificant coronary lesions

  Jose Antonio Esteban-Chapel, Juan Antonio Franco-Peláez, Alvaro Aceña

  Rev Esp Cardiol. 2025;78:590-1

• 1123

  Sleep quality and incident hypertension

  Zhihao Zheng, Yanjun Song, Zechen Liu, Jining He, Shanshan Shi, Chenxi Song, Rui Fu, Lei Jia, Guofeng Gao, Qiuting Dong, Min Yang, Wenjun Ma, Kefei Dou

  Rev Esp Cardiol. 2025;78:600-8

• 1137

  Development and rollout of a national plan on cardiovascular health. Spain's cardiovascular health strategy (ESCAV)

  Héctor Bueno, Germán Seara, María Rosario Azcutia, María Jesús Rodríguez-García, Sonia Peláez, Yolanda Agra, Carla A. Dueñas, Pedro Gullón, Pilar Aparicio Azcárraga, on behalf of the Estrategia en Salud Cardiovascular del Sistema Nacional de Salud ESCAV Multidisciplinary Advisory Committee

  Rev Esp Cardiol. 2025;78:628-36

• 1178

  Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact

  Ariana Gonzálvez-García, Pedro Cepas-Guillén, Julien Ternacle, Marina Urena, Alberto Alperi, Asim N. Cheema, Gabriela Veiga-Fernández, Luis Nombela-Franco, Victoria Vilalta, Giovanni Esposito, Francisco Campelo-Parada, Ciro Idolfi, María del Trigo, Antonio Muñoz-García, Nicolás Maneiro, Luis Asmarats, Ander Regueiro, David del Val, Vicenç Serra, Vincent Auffret, Melchior Jonveaux, Guillaume Bonnet, Jules Mesnier, Suc Gaspard, Pablo Avanzas, Effat Rezaei, Víctor Fradejas-Sastre, Gabriela Tirado-Conte, Eduard Fernández-Nofrerías, Anna Franzone, Thibaut Guitteny, Sabato Sorrentino, Juan Francisco Oteo, Felipe Díez-Delhoyo, Lola Gutiérrez-Alonso, Pablo Vidal, Fernando Alfonso, Andrea Monastyrski, Maxime Nolf, Emilie Pelletier-Beaumont, Marisa Avvedimento, Josep Rodés-Cabau

  Rev Esp Cardiol. 2025;78:618-27

• 1211

  Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako)

  Fernando Alfonso, Jorge Salamanca, Iván Núñez-Gil, Borja Ibáñez, Juan Sanchis, Manel Sabaté, Maite Velázquez, Sergio Raposeiras-Roubín, Tamara García-Camarero, Paula Antuña, Hernán Mejía, Xavier Carrillo, Irene Buera, Manuel Martínez-Sellés, Juan Manuel Escudier-Villa, Joaquín Sánchez-Prieto, Emilia Blanco Ponce, Gonzalo Cabezón, Covadonga Fernández-Golfín, Domingo Pascual-Figal, Belén Cid, Ana Marcano, Rafael González-Manzanares, Santiago Jiménez-Valero, José Manuel Vázquez, Jorge Sanz-Sánchez, Alberto Cecconi, David Del Val, Francisco Abad-Santos, Filippo Crea

  Rev Esp Cardiol. 2025;78:592-9

• 6617

  Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM

  Antonia Sambola, Raquel Campuzano, Almudena Castro, María Goya, Pluvio Coronado, Rosa Fernández-Olmo, Miguel Ángel María-Tablado, Carolina Ortiz-Cortés, Xènia Ortolà, Vicente Pallarés-Carratalá, Antonia Pijuan-Domenech, Rosa M. Plata, Rosa María Sánchez-Hernández, José Manuel Siurana, Càtia Timoteo, Begoña Viejo-Hernández

  Rev Esp Cardiol. 2025;78:639-51